Portal de Periódicos da CAPES

Combining Methylphenidate and Clonidine: Pharmacologic Questions and News Reports about Sudden Death

1995; Mary Ann Liebert, Inc.; Volume: 5; Issue: 3 Linguagem: Inglês

10.1089/cap.1995.5.157

1557-8992

Charles W. Popper,

Attention Deficit Hyperactivity Disorder

Journal of Child and Adolescent PsychopharmacologyVol. 5, No. 3 Combining Methylphenidate and Clonidine: Pharmacologic Questions and News Reports about Sudden DeathCHARLES W. POPPERCHARLES W. POPPERPublished Online:29 Jan 2009https://doi.org/10.1089/cap.1995.5.157AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByMedications14 December 2018Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)20 January 2017Clinical and Pharmacologic Considerations for Guanfacine Use in Very Young Children1 August 2016 | Journal of Child and Adolescent Psychopharmacology, Vol. 26, No. 6Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden3 June 2016Attention-Deficit/Hyperactivity Disorders26 February 2014Psychostimulants and Other Drugs Used in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)26 February 2014A Review of the Rationale and Clinical Utilization of α2-Adrenoceptor Agonists for the Treatment of Attention-Deficit/Hyperactivity and Related Disorders19 June 2013 | Journal of Child and Adolescent Psychopharmacology, Vol. 23, No. 5Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate25 April 2013 | Drugs in R&D, Vol. 13, No. 2Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release22 March 2013 | Drugs in R&D, Vol. 13, No. 1Clinical Pharmacology of Comorbid Attention Deficit Hyperactivity Disorder in Tourette SyndromeAlpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)15 August 2012A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 51, No. 1Attention-Deficit Hyperactivity DisorderTDAH CON NEGATIVIDAD Y AGRESIVIDADTDAH CON TRASTORNOS DEL SUEÑO Y LA ALERTATRATAMIENTO FARMACOLÓGICO DEL TDAH Y LAS COMORBILIDADESPsychopharmacological Management of Children and AdolescentsSafety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder30 October 2009 | Journal of Child and Adolescent Psychopharmacology, Vol. 19, No. 5Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder11 June 2009 | Journal of Child and Adolescent Psychopharmacology, Vol. 19, No. 3Psychopharmacological Treatment of Oppositional Defiant DisorderCNS Drugs, Vol. 23, No. 1Autistische Störungen (Tief greifende Entwicklungsstörungen, ICD-10 F84)Aggressives und autoaggressives Verhalten, Impulskontrollstörung, Störung des SozialverhaltensCHILD AND ADOLESCENT PSYCHOPHARMACOLOGYSubstanzgebundene Alternativen in der Therapie von ADHSZeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, Vol. 37, No. 1Insomnia, Night Terror, and Depression Related to Clonidine in Attention-Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, Vol. 28, No. 6ADHD and hyperkinetic disorderAdverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity DisorderCNS Drugs, Vol. 22, No. 3Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 46, No. 7Research in child and adolescent psychopharmacology: recent accomplishments and new challenges23 May 2006 | Psychopharmacology, Vol. 191, No. 1Clonidine and Related Imidazoline DerivativesDecreased Use of Clonidine Following Treatment With Atomoxetine in Children With ADHDJournal of Clinical Psychopharmacology, Vol. 26, No. 4Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder9 January 2014 | Expert Review of Neurotherapeutics, Vol. 6, No. 4Syncope in children with Tourette's syndrome treated with guanfacine14 October 2005 | Movement Disorders, Vol. 21, No. 3Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentaryEuropean Child & Adolescent Psychiatry, Vol. 15, No. 1New Directions in the Treatment of Comorbid Attention Deficit Hyperactivity Disorder and Tourette's Syndrome8 April 2013Autistische StörungAggressives und autoaggressives Verhalten, Impulskontrollstörung, Störung des SozialverhaltensLes médicaments stimulants et leurs alternatives dans le traitement psychopharmacologique du syndrome de l'hyperactivité infantile15 January 2004 | Perspectives Psy, Vol. 43, No. 1A Randomized Controlled Trial of Clonidine Added to Psychostimulant Medication for Hyperactive and Aggressive ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 42, No. 8Tourette's syndrome: Are stimulants safe?Current Neurology and Neuroscience Reports, Vol. 3, No. 4Adrenergic Agents in Child and Adolescent Psychiatry3 December 2009Overview of current management of sleep disturbances in children: I—PharmacotherapyCurrent Therapeutic Research, Vol. 63Rational pharmacotherapy for childhood sleep disturbances: Characteristics of an ideal hypnoticCurrent Therapeutic Research, Vol. 63Intermittent Explosive DisorderCNS Drugs, Vol. 16, No. 8Insomnia in ChildrenPediatric Drugs, Vol. 4, No. 6Insomnia in ChildrenPediatric Drugs, Vol. 4, No. 6ATTENTION-DEFICIT/HYPERACTIVITY DISORDERMedical Clinics of North America, Vol. 85, No. 3Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity DisorderClinical Pharmacokinetics, Vol. 40, No. 10Pharmacological Alternatives to Psychostimulants for the Treatment of Attention-Deficit/Hyperactivity DisorderChild and Adolescent Psychiatric Clinics of North America, Vol. 9, No. 3Pharmacotherapy of Attention Deficit Hyperactivity DisorderChild and Adolescent Psychiatric Clinics of North America, Vol. 9, No. 1Pharmacologic Treatment of Tic DisordersChild and Adolescent Psychiatric Clinics of North America, Vol. 9, No. 1A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct Disorder2 July 2016 | Clinical Pediatrics, Vol. 39, No. 1CLONIDINE AND METHYLPHENIDATEJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 12Developmental Features of SleepChild and Adolescent Psychiatric Clinics of North America, Vol. 8, No. 4Psychophartnacology Notes Alpha-2 Agonists in the Treatment of Attention Deficit Hyperactivity DisorderJournal of Child and Adolescent Psychiatric Nursing, Vol. 12, No. 4Case Series: Clonidine Has No Systematic Effects on PR or QTc Intervals in ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 9NEGATIVE REBUTTAL: SWANSON ET ALJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 5Anxiolytics, Adrenergic Agents, and NaltrexoneJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 5Psychoactive Medication Prescribing Practices for U.S. Children: Gaps Between Research and Clinical PracticeJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 5Combining Methylphenidate and Clonidine: A CLINICALLY SOUND MEDICATION OPTIONJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 5Anxiolytics, Sedatives, and Miscellaneous DrugsStimulantsα2 ADRENERGIC AGONISTSPediatric Clinics of North America, Vol. 45, No. 5Child and Adolescent PsychopharmacologyPharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorderHuman Psychopharmacology: Clinical and Experimental, Vol. 12, No. 6Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorderHuman Psychopharmacology: Clinical and Experimental, Vol. 12, No. 6Safety of Combined PharmacotherapyJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 36, No. 11Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorderHuman Psychopharmacology: Clinical and Experimental, Vol. 12, No. 6Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorderHuman Psychopharmacology: Clinical and Experimental, Vol. 12, No. 6SAFETY OF COMBINED PHARMACOTHERAPYJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 36, No. 11Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 36, No. 10An Update on Psychopharmacologic Medication27 July 2016 | Intervention in School and Clinic, Vol. 33, No. 1ATTENTION DEFICIT HYPERACTIVITY DISORDER IN THE PRESENCE OF TOURETTE SYNDROMENeurologic Clinics, Vol. 15, No. 2Case Study: Adverse Response to ClonidineJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 36, No. 4Nonstimulant Medications in the Treatment of Attention Deficit Hyperactivity DisorderJournal of Child and Adolescent Psychiatric Nursing, Vol. 9, No. 2Clinical pharmacology of sleep disturbances in children and adolescents Volume 5Issue 3Jan 1995 To cite this article:CHARLES W. POPPER.Combining Methylphenidate and Clonidine: Pharmacologic Questions and News Reports about Sudden Death.Journal of Child and Adolescent Psychopharmacology.Jan 1995.157-166.http://doi.org/10.1089/cap.1995.5.157Published in Volume: 5 Issue 3: January 29, 2009PDF download